s81694
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2018 (NCT03411161)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dual specificity protein kinase TTKINHIBITOR
TTK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03411161 | Phase 1/Phase 2 (Phase 2) | Jan 4, 2018 | ADIR Association, Institut de Cancerologie de l'Ouest Paul Papin, Servier |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ADIR Association | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Institut de Cancerologie de l'Ouest Paul Papin | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Servier | For profit | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1